ey0019.6-16 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19
Blok CJ de
, CM Wiepjes
, Velzen DM van
, AS Staphorsius
, NM Nota
, LJ Gooren
, BP Kreukels
, Heijer M den
Lancet Diabetes Endocrinol. 2021 Oct;9(10):663-670. PMID: 34481559, doi: 10.1016/S2213-8587(21)00185-6. Brief Summary: This paper reports standardised mortality rates (SMR) between 1972 and 2018 in a large cohort of 2927 transgender women and 1641 transgender men from the Amsterdam Cohort of Gender Dysphoria. It finds a higher SMR for transgender women compared with transgender men. </p...